Ouvrages publiés en collaboration (1)

  1. 1. Vertongen, P., Schiffmann, S. N., Gourlet, P., & Robberecht, P. (1998). Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain.: Ann N.Y. Acad Sci, 865: 412-415.
  2.   Parties d'ouvrages collectifs (1)

  3. 1. Robberecht, P., Vertongen, P., Langer, I., & Perret, J. (2003). Pituitary Adenylate Cyclase-Activating Polypeptide: Development of Selective Ligands for Pac1, Vpac1 and Vpac2 Receptors. In H. Vaudry & A. Arimura (Eds.), Pituitary Adenylate Cyclase-Activating Polypeptide: Development of Selective Ligands for Pac1, Vpac1 and Vpac2 Receptors, Vol. 20. Endocrine Updates (pp. 49-67). Springer US. doi:10.1007/978-1-4615-0243-2_3
  4.   Articles dans des revues avec comité de lecture (50)

  5. 1. Hernigou, J., Vertongen, P., Rasschaert, J., & Hernigou, P. (2021). Role of scaffolds, subchondral, intra-articular injections of fresh autologous bone marrow concentrate regenerative cells in treating human knee cartilage lesions: Different approaches and different results. International journal of molecular sciences, 22(8), 3844. doi:10.3390/ijms22083844
  6. 2. Dalla Valle, A., Vertongen, P., Spruyt, D., Lechanteur, J., Suain, V., Gaspard, N., Brion, J. P., Gangji, V., & Rasschaert, J. (2019). Induction of Stearoyl-CoA 9-Desaturase 1 Protects Human Mesenchymal Stromal Cells Against Palmitic Acid-Induced Lipotoxicity and Inflammation. Frontiers in endocrinology, 10, 726. doi:10.3389/fendo.2019.00726
  7. 3. Hernigou, J., Vertongen, P., Chahidi, E., Kyriakidis, T., Dehoux, J. P., Crutzen, M., Boutry, S., Larbanoix, L., Houben, S., Gaspard, N., Koulalis, D., & Rasschaert, J. (2018). Effects of press-fit biphasic (collagen and HA/βTCP) scaffold with cell-based therapy on cartilage and subchondral bone repair knee defect in rabbits. International orthopaedics, 42(7), 1755-1767. doi:10.1007/s00264-018-3999-3
  8. 4. Gillet, C., Dalla Valle, A., Gaspard, N., Spruyt, D., Vertongen, P., Lechanteur, J., Rigutto, S., Dragan, E.-R., Heuschling, A., Gangji, V., & Rasschaert, J. (2017). Osteonecrosis of the Femoral Head: Lipotoxicity Exacerbation in MSC and Modifications of the Bone Marrow Fluid. Endocrinology, 158(3), 490-502. doi:10.1210/en.2016-1687
  9. 5. Prévost, M., Vertongen, P., & Waelbroeck, M. (2012). Identification of key residues for the binding of glucagon to the N-terminal domain of its receptor: an alanine scan and modeling study. Hormone and Metabolic Research, 44(11), 804-809. doi:10.1055/s-0032-1321877
  10. 6. Roberts, D. J., Vertongen, P., & Waelbroeck, M. (2011). Analysis of the glucagon receptor first extracellular loop by the substituted cysteine accessibility method. Peptides, 32(8), 1593-1599. doi:10.1016/j.peptides.2011.06.009
  11. 7. Prévost, M., Vertongen, P., Raussens, V., Roberts, D. J., Cnudde, J., Perret, J., & Waelbroeck, M. (2010). Mutational and cysteine scanning analysis of the glucagon receptor N-terminal domain. The Journal of biological chemistry, 285(40), 30951-30958. doi:10.1074/jbc.M110.102814
  12. 8. Xu, L., Depoortere, I., Vertongen, P., Waelbroeck, M., Robberecht, P., & Peeters, T. L. (2005). Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor. Biochemical pharmacology, 70(6), 879-887. doi:10.1016/j.bcp.2005.06.022
  13. 9. Lambeng, N., Gillard, M., Vertongen, P., Fuks, B., & Chatelain, P. (2005). Characterization of [(3)H]ucb 30889 binding to synaptic vesicle protein 2A in the rat spinal cord. European journal of pharmacology, 520(1-3), 70-76. doi:10.1016/j.ejphar.2005.07.029
  14. 10. Langlet, C., Langer, I., Vertongen, P., Gaspard, N., Vanderwinden, J.-M., & Robberecht, P. (2005). Contribution of the carboxyl terminus of the VPAC1 receptor to agonist-induced receptor phosphorylation, internalization, and recycling. The Journal of biological chemistry, 280(30), 28034-28043. doi:10.1074/jbc.M500449200

  15. << Précédent 1 2 3 4 5 Suivant >>